Dharmanol discussion here has focused on non-psychoactive

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles
Dharmanol discussion here has focused on non-psychoactive CBD and THCA as two powerful medicinal agents. Little has been said about CBDA. THCA and CBDA are both cannabinoid carboxylates. Dharmanol, with its CBD and "mixed cannabinoid carboxylates," would also contain CBDA.

We know that THC is the psychocactive delta9-tetrahydrocannabinol which, in its native form in the living cannabis plant, is non-psychoactive tetrahydrocannabinolic acid (THCA or 2-COOH-THC). Heating, vaporizing or drying THCA strips off (decarboxylates) the carboxyl radical (-COOH) leaving psychoactive THC. CBDA is  cannabidiolic acid. As with THCA, stripped of its -COOH radical, it becomes CBD or cannabidiol.

H-COOH is the simplest carboxylic organic acid. Called formic acid, it has the odor of ants (genus formica). Formic acid is found in ant venom. CH3-COOH is acetic acid, the sour chemical in vinegar. It's thought that THCA and CBDA help protect the cannabis plant from microbial and insect predation.

Recent research has shown CBDA, which has anti-inflammatory properties greater than THCA, to have powerful healing properties including management of schizophrenia.

According to Dr. Mitch Earleywine, researchers at Harvard showed that CBDA makes breast cancer cells kill themselves and researchers in Japan found CBDA keeps breast cancer cells from spreading.

This is further evidence that Berkeley Bio's proprietary and carefully calibrated Whole Plant Plus technology, to coin a phrase, as formulated in Dharmanol™ is the correct scientific and medical methodology that will win the marketplace.

From Hoye essay:

"Along with the CBD and mixed cannabinoid carboxylates, the third component of Dharmanol™ is a steam-distilled extract of a variety of strains of cannabis. This preparation contains the terpenes and terpenoids found in marijuana, many of which have been shown to have substantial medicinal value in themselves, as well as potentiating the activity of some of the cannabinoids."

"Low-dose tablets contain 5mg. CBD, 5 mg. mixed cannabinoid carboxylates, and 5 mg. of steam-distilled terpenes and terpenoids. A daily supplement such as this will gently stimulate the endo-cannabinoid system, which regulates and enhances many of the body’s own health-promoting processes, such as the immune system. These are the systems that keep cancer and other opportunistic diseases in check in otherwise-healthy individuals."

More on Dharmanol™ in the Hoye essay on :

"CBD is an important part of Dharmanol™ a new natural medicine recently developed by Berkeley Bio. Along with CBD, Dharmanol™ contains a wide array of natural cannabinoids that have been extracted from hemp/cannabis and preserved in their non-psychoactive form utilizing a proprietary technology developed by Gold and Apel."

"...the carboxylates present in Dharmanol™ go a long way towards providing the same benefits without the extreme difficulty of maintaining live marijuana plants."

"Dharmanol™ has been designed to provide the widest spectrum of beneficial compounds of the cannabis plant, in their non-psychoactive form..." 

" Dharmanol™ has been designed to provide the widest spectrum of beneficial compounds of the cannabis plant, in their non-psychoactive form, just as the aforementioned capsules provided the widest healing array possible, but included the psychoactive THC."

"Dharmanol™ has been designed to treat any of the myriad of conditions for which physicians are now recommending that patients try cannabinoid medicine. Modern research tells us that this includes treatments for a great number of different conditions."

"Two additional benefits are present with Dharmanol™ that are not to be found with standard Simpson therapy. The removal of the psychoactivity allows patients who cannot tolerate Simpson oil to treat their conditions with adequate amounts of cannabinoids, and the removal of the psychoactivity allows patients to tolerate much larger doses."

"The capacity to increase the dosage by removing the psychoactivity holds much promise. The “standard” Simpson dose is well under one one-thousandth of the dose of cannabinoids said to be capable of causing physical harm to the organism. The reason that one gram is the dose recommended by Simpson is that few people could possibly tolerate more than this."

"With the amazing anecdotal results surrounding Simpson oil, combined with the fact that many of cannabis’ mechanisms are dose-dependent, it stands to reason that increasing the daily dose of cannabinoids ten, or perhaps one hundred times, could provide a medicine that no cancer could possibly stand up against. Hopefully, clinical trials of Dharmanol™ will show whether this is so."


SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 4

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 2

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 2

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 0

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 3

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 4

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 1

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 3

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading

Top 5 Most Recently Viewed Articles

Integrated Rail and Resources Acquisition Corp. Business Update

Updated Category News Views 154

Integrated Rail and Resources Acquisition Corp. Business Extension Integrated Rail and Resources Acquisition Corp. is taking strategic steps to extend its timeline for finalizing a business combination. Recent communications from its sponsor, DHIP Natural Resources Investments, LLC, indicate that the Company will push back its deadline from December 15, 2025, to January...

Continue Reading
Bitcoin Solaris Sees Surge in Investor Interest Pre-Launch

Updated Category News Views 124

Bitcoin Solaris: A New Era in Cryptocurrency Bitcoin Solaris (BTC-S) has become a key player in the cryptocurrency landscape, as its presale gains remarkable traction with over 11,500 investors contributing, raising more than $5 million. With less than seven weeks to go before launching on major exchanges, the excitement and confidence surrounding this innovative...

Continue Reading
QuantiPath.bio: A New Era in Food Safety Testing Solutions

Updated Category News Views 434

QuantiPath.bio: A New Identity for Food Safety Innovation In a remarkable transformation, Food Supply Security has officially adopted the name QuantiPath.bio. This bold rebranding marks a significant moment, embodying the commitment to innovation and a new vision for the future of food safety testing. The Groundbreaking Product: GenoPATHx At the forefront of QuantiPath's...

Continue Reading
Evaxion Biotech Modifies ADS Ratio Change Timeline

Updated Category News Views 139

Evaxion Biotech Announces Changes to ADS Ratio Evaxion Biotech A/S (NASDAQ: EVAX), a leader in the TechBio sector focusing on AI-powered vaccines, has made an important announcement regarding the adjustment of the ratio of its American Depositary Shares (ADS) to its ordinary shares. This decision reflects Evaxion's commitment to enhancing investor liquidity as it...

Continue Reading
AtkinsRéalis Expands Horizons with C2AE Acquisition

Updated Category News Views 149

AtkinsRéalis Expands Horizons with C2AE Acquisition AtkinsRéalis Group Inc. (TSX: ATRL) has recently enhanced its portfolio by acquiring C2AE, Inc., an established architecture and engineering firm based in Michigan. This strategic move further solidifies AtkinsRéalis’ commitment to expanding its presence within the U.S., particularly in the Upper Midwest region....

Continue Reading